ImCheck Therapeutics (private company)

imchecktherapeutics.com

See something wrong or missing? Let us know

Offices:Marseille

Industry: Biotech Health services Pharma

Business model: B2B

ImCheck Therapeutics is a developing novel therapeutics that target members of the butyrophilin (BTN) super-family of checkpoint molecules.

Investors: we tracked 8 investors

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.